FDA Drug Application (086513) for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE by MYLAN

Back to FDA Applications sponsored by MYLAN

Application Number086513
Product Number001
FormTABLET;ORAL
Dosage25MG;25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; SPIRONOLACTONE



Back to FDA Applications sponsored by MYLAN

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.